SMO and chronic myelogenous leukemia, BCR-ABL1 positive: Smo overexpression in human CML cell lines is also associated with reduced expression of miR-326 in CD34+ CML LSCs, and overexpression of miR-326 leads to Smo downregulation and, consequently, decreased cell viability [106].